Tag: WLLW.CN

420 with CNW – Pennsylvania Governor Wolf Announces His Support for Recreational Marijuana Legalization

In a press conference on Wednesday, Tom Wolf, Pennsylvania Governor accompanied by Lt. Gov. John Fetterman, announced his support for the legalization of adult-use recreational marijuana. In his announcement, he included the final report from Lt. Governor John Fetterman’s statewide tour on recreational marijuana legalization. He also proposed the next steps to be taken after reviewing the input submitted by the citizens from the 67 counties who attended their listening sessions or reverted via their online platform.

In his announcement, Governor Wolf said that Lt.Governor Fetterman fulfilled his promise of touring all the 67 counties in Pennsylvania to get the opinion of the citizens regarding the legalization of adult-use recreational marijuana. Moreover, the majority of the feedback received was in favor of recreational marijuana legalization.

Lt. Governor John Fetterman invited the public, media companies and local officials to the tour stops in each county, where the attendees indicated their interest in the bill by a show of hands.

The report comprises of two parts. The first part looks at the volume of messages sent to the online platform hosted on the governor’s website, the comments made on the platform and comment cards collected at the tour stops, as well as any additional message received by the Lt. Gov Fetterman in other formats.

During the announcement, the Lt. Governor voiced his appreciation for the Pennsylvania citizens who attended his tours and those who submitted their comments either physically or online. He also assured the Pennsylvanians that they will do their best to bring into effect the proposed changes.

Apart from announcing the report, the Pennsylvania Governor and Lt. Governor called for the legislature to get a bill that decriminalizes non-violent and cannabis-related offenses to the governor’s desk. They also announced that they are seeking justice by expunging non-violent and small cannabis-related crimes convicted in the past. Finally, they are asking the General Assembly to debate and pass the bill legalizing recreational marijuana.

Since the majority of Pennsylvania residents are in favor of recreational marijuana legalization, Governor Wolf says that he is looking forward to accomplishing many missions together. This includes the criminal justice reform that he is proposing as it will positively affect the people of Pennsylvania.

In his final remarks, Governor Wolf expressed his gratitude to Lt. Gov. John Fetterman for touring the 67 counties and conducting the research. More gratitude was directed towards the Pennsylvanians who attended the tour stops, wrote messages or called the headquarters to voice their opinion.

Analysts are of the view that industry players like Youngevity International Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) will only be happy for the people of Pennsylvania once a legalization bill is passed and signed off.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – A Historic Vote Approves the Marijuana Banking Bill in the House

On Wednesday, the House of Representatives made history by passing a standalone cannabis reform bill. The bill aims to protect financial institutions and ancillary firms that provide services to legitimate marijuana companies in the United States. The legislation would guarantee stability and security to the multibillion-dollar marijuana industry as well as ensuring public safety.

A vote of 321 passed The Secure and Fair Enforcement (SAFE) Banking Act. All Democrats but one voted for the bill while  91 Republicans voted for the bill and 102 opposed it. For the bill to pass, it required a two-thirds majority of the House to vote for it.

In the United States, recreational marijuana is legal in eleven states, including the Columbian District. Moreso, most of the states in the U.S have legalized the use of medical marijuana. However, at the federal level, marijuana is still considered illegal, making financial institutions and credit unions dread conducting business with marijuana businesses out of fear of being prosecuted or facing the consequences of not abiding by the regulations.  The SAFE Banking Act will protect these institutions from the effects of conducting business with marijuana companies and enterprises.

In March, the bill moved out of the House Finance Committee. Before the vote on Wednesday, the bill had tallied 200 sponsors of which 26 were Republicans. Several national banking groups are supporting the bill by pushing Congress to take action. These groups include American Bankers Association, Independent Community Bankers of America, and the Credit Union National Association. The National Association for State Treasurers, plus state attorneys general and governors from 20 different states all urged Congress to approve the bill.

Although some human rights groups are against the bill claiming that it would be a hindrance to other reforms and federal legalization; the cannabis trade groups, some human right groups, and people advocating for marijuana legalization are in favor of the bill.

Neal Levine, the CEO of the Cannabis Trade Federation (CTF), said that the federation applauds the House for passing the SAFE Banking Act and that they hope that the Senate will follow suit. He also said that the bill benefits the cannabis businesses and the communities that have chosen to embrace cannabis legalization. The Bill allows weed businesses to access banking services; thus, eliminating their reliance on cash. This will, in turn, improve safety within the community, transparency within the industry and adherence to cannabis-related regulations.

It is still not clear if the bill will be approved in the Republican-controlled Senate, but experts are in agreement that industry participants, such as Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Willow Biosciences Inc. (CSE: WLLW), are keeping their fingers crossed hoping that the upper chamber also passes the bill.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Massachusetts Lawmakers Move to Address Vaping Dangers

Reports about illnesses and some fatalities possibly linked to the use of tainted vape cartridges has prompted lawmakers and state officials across the country to look for ways to address this challenge. Massachusetts is one of the states that has come out swiftly to confront this problem head-on.

On Thursday last week, the Cannabis Control Commission in Massachusetts voted unanimously to enforce new rules requiring marijuana cartridge manufacturers to list all the ingredients in their products.

Previously, those manufacturers were only expected to indicate the THC concentration and the other cannabinoids in the product. The new rules change this and require product labels to have information on all ingredients, including additives, terpenes and the thickening agents used.

The additives used in vape cartridges have attracted heightened scrutiny of late after health authorities in New York suggested that the spate of vape-related illnesses and deaths could be linked to Vitamin E acetate added to knock-off cartridges.

Steven Hoffman, the chairman of the Cannabis Control Commission, stated that one way that state regulators can help consumers is by giving them more information so that they consume products more responsibly. The added labeling requirements are intended to give consumers more information, he added.

The Cannabis Control Commission staff have also been directed by their Executive Director to collaborate more with testing labs in the state so that those facilities can develop testing protocols for all the additives included in vape cartridges.

The Cannabis Control Commission isn’t the only agency that is acting in response to the risks of tainted vape cartridges. The Public Health Department has also issued a directive to all healthcare providers to report to the department any illnesses linked to vaping cannabis cartridges.

So far, no such illnesses have been reported in Massachusetts, and the authorities want to do everything possible to keep it that way.

The same cannot be said for New Jersey which has so far registered 19 cases of the mysterious respiratory illness that has come to be linked to vaping marijuana. To contain that problem, Gov. Phil Murphy has created a special task force and given them sweeping authority to suggest any policy changes that can put the problem to an end and protect public health.

The governor doesn’t see how the problems associated with tainted vape cartridges will affect plans to legalize recreational marijuana in the state, so he wants the Assembly speaker and other Democratic leaders to move ahead with plans to table a new marijuana legalization bill.

Experts believe that the problem of tainted cartridges must be giving industry actors like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Willow Biosciences Inc. (CSE: WLLW) sleepless nights too since they damage the good name of the industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference

Willow Biosciences Inc. (CSE: WLLW) today announced its plans to participate at the Eight Capital & Cassels Brock Global Cannabis Conference slated to be held at the Shangri-La Hotel in Toronto on September 19, 2019. Willow Biosciences will be available for one-on-one meetings during the event. In addition, Willow CEO, President and Director Trevor Peters will present in the panel, “Pushing the Boundaries Through Technology, Innovation & Research,” at 10:30 a.m. Eastern Time in the Queen’s Park Ballroom.

To view the full press release, visit http://cnw.fm/LS4j3

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Highlighted in Comprehensive Research Report

Willow Biosciences (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, was recently covered in a research report by Eight Capital. Per the report, Eight Capital issued a ‘Buy’ rating and a target price of $4.50 for WLLW, determined in part by Willow’s chosen method of cannabinoid production, biosynthesis, which holds the potential to disrupt the industry. The report also detailed upcoming catalysts for the company, including the potential formation of partnerships and agreements; quantitative milestones demonstrating increased throughput of the company’s proprietary yeast strains; planned uplisting to the Toronto Stock Exchange; and securing intellectual property (“IP”) assets. For detailed information regarding the research report, contact Info@WillowBio.com.

For more information, visit www.WillowBio.com.

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Stock Option Grant and Unit Issuance

Willow Biosciences Inc. (CSE: WLLW) on Tuesday announced that it has granted an aggregate of 1,118,000 stock options for certain employees to purchase common shares of Willow pursuant to the terms and conditions of its stock option plan. According to the update, the options expire five years from the grant date, are exercisable at a price of $0.60 per common share, and vest as to one third on the grant date and on each of the first and second anniversaries of the grant date. Willow has additionally issued 21,057 units of the company in connection with its previous April 2019 private placement. The units were issued as of the date hereof, each at an issuance price of $0.875 and consisting of one common share and one performance-based common share purchase warrant. The units were issued at the same price (on a post-consolidation basis) and the warrants have the same terms as those issued under the company’s April 2019 private placement.

To view the full press release, visit http://cnw.fm/cyrM7

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Mississippians Likely to Vote on Medical Cannabis After Ballot Measure Signatures Are Submitted

Voters in Mississippi are likely to be given a chance to cast their vote to decide whether medical marijuana should be legalized in the state after a group of activists submitted a list containing more than the minimum number of voter signatures required to put the matter on the 2020 ballot.

Though the signatures that were submitted on Wednesday this week still have to be verified by the Mississippi Secretary of State, Mississippians for Compassionate Care (MCC), the group behind the campaign to put the matter before voters, are confident that all is set after they submitted lists containing in excess of 214,000 voter signatures.

Out of that total number of signatures, clerks in different counties have already certified at least 105,686 signatures. This number alone exceeds the minimum number of voter signatures required by 20,000.

The office of the secretary of state confirmed that the medical marijuana petition had been filed and the process of verifying the signatures had started so that the department would be ready to submit that petition to the state legislature on their first day of business in 2020 if everything is as it should be regarding the signatures collected.

Hitting the target number in terms of voter signatures isn’t the only requirement that the activists had to meet. They also had to make sure that they obtained certain voter signature numbers from voters in the different congressional districts within the state if the petition was to stand a chance of making it onto the ballot.

The MCC is confident that all those requirements were met since the campaigners received overwhelming support from the people as the group collected signatures.

If the measure is approved by voters during the 2020 election, patients suffering from a variety of debilitating conditions, including cancer and chronic pain, would be eligible to use medical marijuana. The petition has a list of 22 conditions for which patients can apply to be certified and start using medical marijuana.

The patients would be allowed to purchase and possess up to 2.5 ounces of medical marijuana products within a 14-day timeframe before they can purchase more products.

Collecting signatures to put the matter on the ballot is one thing, and getting the majority of voters to support the measure is another thing altogether. However, the activists are confident that with opinion polls showing 77 percent support among Mississippians, the medical marijuana ballot measure is likely to sail through.

Before that happens, the Mississippians for Compassionate Care activists have to contend with opposition from the Board of Health in the state and from Gov. Phil Bryant (R).

Experts are in agreement that marijuana industry players like Willow Biosciences Inc. (CSE: WLLW) and Youngevity International Inc. (NASDAQ: YGYI) will be hoping that the ballot measure delivers medical marijuana to the state so that patients can have more options as they look for remedies for their specific ailments.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Engages The Howard Group; Presenting at the 8th Annual Gateway Conference

Willow Biosciences (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, on Tuesday announced its engagement of The Howard Group as its capital markets communications advisor. The engagement is for twelve months at a fee of $9,000 per month, effective August 15, 2019, and is renewable after six months. In this role, The Howard Group will assist Willow with traditional and online initiatives that target the investment community in addition to institutional and retail investing groups. The Howard Group will also provide ongoing commentary on the company’s activities through its blog (http://cnw.fm/7VSvJ). Additionally, Willow announced that it will be presenting at the 8th Annual Gateway Conference taking place at the Four Seasons Hotel in San Francisco at 1:00 PM PT on Thursday, September 5th. Willow management will also be holding one-on-one meetings throughout the conference.

To view the full press release, visit http://cnw.fm/I7CJh

About Willow Biosciences Inc.

Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Releases Q2 2019 Results and Provides Operational Update

Willow Biosciences (CSE: WLLW) today released its financial results for the three and six months ended June 30, 2019 and provided an operational update. Among highlights for the quarter, the company reported that it has: expanded its operations to include three facilities located in Calgary, Alberta, Mountain View, California and Burnaby, British Columbia; made key appointments to its management team and board of directors; entered an exclusive Joint Development Agreement (“JDA”) with Noramco; and completed a reverse takeover and raised gross proceeds of approximately $37.0 million. “Over the past few months, we have made impressive progress in advancing our business on several important fronts,” Willow President and Chief Executive Officer Trevor Peters said in the news release. “We have assembled a team of proven business executives and world-renowned scientists to lead the development of our high-quality consumer, wellness, and pharmaceutical ingredient manufacturing programs. The development of our yeast-based cannabinoid production platform is progressing well and we expect to initiate the scaling up of our process in the first half of 2020. In addition to advancing our development operations, we are focused on positioning Willow for successful future commercialization through our recently signed strategic partnership with Noramco, Inc. (Noramco), one of the world’s leading pharmaceutical cannabinoid ingredient producers.”

To view the full press release, visit http://cnw.fm/Nh99B

About Willow Biosciences Inc.

Headquartered in Calgary, Canada, Willow and its team of scientists are leaders in the field of biosynthetic production of high-value, plant-derived compounds. Willow has applied its integrated suite of technologies to develop manufacturing processes for numerous active pharmaceutical ingredients with various therapeutic benefits, including cancer treatment, pain management and CNS disorders. In the cannabinoid field, Willow owns proprietary, yeast-based lab strains that produce CBD, tetrahydrocannabinol (THC) and cannabigerol (CBG), as well as certain minor and novel cannabinoids. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Federally Funded Journal Reveals How Prohibition is Endangering Marijuana Consumers

It is ironical that federal dollars were used to publish a journal report which blames the federal prohibition of marijuana for putting cannabis consumers at risk since there is no federal guidance on the safety standards that the industry should adhere to.

Environmental Health Perspectives, an open access journal whose work is supported by funding from the National Institutes of Health, published this damning report in its edition for this week.

The report observes that because marijuana is still considered an illegal drug by the federal government, regulatory agencies like the FDA and the EPA cannot provide guidance to the industry on how matters of consumer safety can be addressed.

Consequently, each state that has legalized marijuana in some form has been left to its own devices regarding how to protect the millions of marijuana users.

Concerns about heavy metals, the use of butane during the extraction of concentrates and the presence of microbial contaminants are issues that federal regulators like the EPA and FDA would look into if marijuana was legal federally.

A clear example of how this oversight would work was exemplified last week when the Environmental Protection Agency (EPA) announced that it would soon call for public comment as part of its process of considering applications for pesticides that can be used in hemp fields. Hemp was legalized last year, and that explains why the EPA is stepping in to provide guidance regarding the crop protection products which can be used during the cultivation of industrial hemp.

Because marijuana is still illegal federally, there is no consistency in the implementation of consumer protection since each state has its own laws on the matter.

The journal quotes Ben Gelt, the board chairman of the Cannabis Certification Council, as saying that consumers in non-legal states face the greatest safety risks since there is no regulation at all of the marijuana sold there illegally.

Gelt adds that not a single state that has legalized marijuana has got everything right in terms of the consumer protection measures embedded in the state laws. There is need for a lot of research so that all the gaps can be filled, Gelt stated.

The journal has a disclaimer stating that while it received financial support from the National Institutes of Health and other organizations, such support should not be construed to mean that those entities endorse or condone the views, products, services and any other information contained in the publication.

All the same, experts agree that industry actors like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Willow Biosciences Inc. (CSE: WLLW) must be chuckling at the irony of federal money calling out the federal government for not legalizing marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com